Earn these JavaScript certs to demonstrate mastery of the most in-demand skills for the world’s most-used programming language. JavaScript remains one of the most in-demand programming languages for ...

Follow live BBC coverage, text commentary, score updates and match stats from Aston Villa vs Nottingham Forest in the.

Reaction as Paris St-Germain beat Bayern Munich 6-5 on aggregate to set up Champions League final against Arsenal.

Croatia captain Luka Modric was included in the country’s preliminary World Cup squad on Monday, just weeks after undergoing ...

Trials of the British Army's Ajax armoured vehicle will be "proceeding cautiously" after they were halted last year, a defence minister has said. A decision was made to stop using the Ajax after ...

Total consideration reaches up to $2.3 billion via upfront payment plus milestones tied to predefined clinical and regulatory achievements, subject to customary conditions and Hart-Scott-Rodino ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

Eli Lilly LLY-0.00%increase; green up pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

Ajax have been forced to relocate their crucial European play-off semi-final to FC Volendam's modest Kras Stadion due to a clashing Harry Styles concert series at the Johan Cruijff ArenA. The ...

Trials of the Army's troubled Ajax armoured vehicles will resume "cautiously", with the defence minister acknowledging more work is needed to "rebuild confidence" in the transportation. Testing of the ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...